DR HORTON ● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths
● The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 41.94 USD in weekly data.
● The close medium term support offers good timing for purchasing the stock.
● The company returns high margins, thereby supporting business profitability.
● As regards fundamentals, the enterprise value to sales ratio is at 1.07 for the current period. Therefore, the company is undervalued.
● With a P/E ratio at 11.8 for the current year and 9.66 for next year, earnings multiples are highly attractive compared with competitors.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● For several months, analysts have been revising their EPS estimates roughly upwards.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● The tendency within the weekly time frame is positive above the technical support level at 41.94 USD
